ArticleBioengineering (Basel, Switzerland)2025
Predictive Model of Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia on Event-Free Survival: Data Analysis Based on Trial AAML0531.
Kun-Yin Qiu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.